Cargando…
Therapeutic Targeting Notch2 Protects Bone Micro-Vasculatures from Methotrexate Chemotherapy-Induced Adverse Effects in Rats
Intensive cancer chemotherapy is well known to cause bone vasculature disfunction and damage, but the mechanism is poorly understood and there is a lack of treatment. Using a rat model of methotrexate (MTX) chemotherapy (five once-daily dosses at 0.75 mg/kg), this study investigated the roles of the...
Autores principales: | Peymanfar, Yaser, Su, Yu-Wen, Hassanshahi, Mohammadhossein, Xian, Cory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367713/ https://www.ncbi.nlm.nih.gov/pubmed/35954226 http://dx.doi.org/10.3390/cells11152382 |
Ejemplares similares
-
Notch2 Blockade Mitigates Methotrexate Chemotherapy-Induced Bone Loss and Marrow Adiposity
por: Peymanfar, Yaser, et al.
Publicado: (2022) -
Supplementation with Fish Oil and Genistein, Individually or in Combination, Protects Bone against the Adverse Effects of Methotrexate Chemotherapy in Rats
por: Raghu Nadhanan, Rethi, et al.
Publicado: (2013) -
Roles of MicroRNAs in Osteogenesis or Adipogenesis Differentiation of Bone Marrow Stromal Progenitor Cells
por: Zhang, Ya-Li, et al.
Publicado: (2021) -
Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss
por: Lee, Alice M. C., et al.
Publicado: (2017) -
Notch signalling in healthy and diseased vasculature
por: Del Gaudio, Francesca, et al.
Publicado: (2022)